Marek Samec
Impact in
- Drug Discovery top 0.5%
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- MicroRNA in disease regulation 6
- Cancer, Hypoxia, and Metabolism 5
- Biochemistry 10
- Phytochemicals and Antioxidant Activities 6
- Co-authors
- Peter Kubatka (52 shared papers)Alena Líšková (34 shared papers)Dietrich Büsselberg (37 shared papers)Lenka Koklesová (36 shared papers)Olga Golubnitschaja (30 shared papers)Samson Mathews Samuel (13 shared papers)Kamil Biringer (26 shared papers)Frank Anton Giordano (14 shared papers)
- Journals
- The EPMA Journal (17 papers)International Journal of Molecular Sciences (8 papers)Cancers (8 papers)Biomolecules (5 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- SlovakiaQatarUnited States
In The Last Decade
Marek Samec
77 papers receiving 3.5k citations
Marek Samec's Hit Papers
Peers
Comparison fields: 5 of 122
- Drug Discovery 58
- Cancer Research 570
- Biochemistry 288
- Pharmacology 363
- Biomaterials 230
Countries citing papers authored by Marek Samec
This map shows the geographic impact of Marek Samec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Samec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Samec more than expected).
Fields of papers citing papers by Marek Samec
This network shows the impact of papers produced by Marek Samec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Samec. The network helps show where Marek Samec may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Samec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer Hit paper breakdown → | 2019 | 473 |
| 2 | 2020 | 170 | |
| 3 | 2020 | 162 | |
| 4 | 2021 | 125 | |
| 5 | 2021 | 119 | |
| 6 | 2021 | 117 | |
| 7 | 2020 | 115 | |
| 8 | 2020 | 110 | |
| 9 | 2021 | 109 | |
| 10 | 2020 | 105 | |
| 11 | 2021 | 104 | |
| 12 | 2021 | 87 | |
| 13 | 2019 | 85 | |
| 14 | 2019 | 78 | |
| 15 | 2020 | 77 | |
| 16 | 2019 | 75 | |
| 17 | 2022 | 72 | |
| 18 | 2020 | 70 | |
| 19 | 2021 | 68 | |
| 20 | 2021 | 60 |
About Marek Samec
Marek Samec is a scholar working on Cancer Research, Biochemistry, Pharmacology, Plant Science and Molecular Biology, having authored 77 papers that have together received 3.6k indexed citations. Recurring topics across this work include Medicinal Plant Research (11 papers), Flavonoids in Medical Research (7 papers), Phytochemicals and Antioxidant Activities (6 papers), MicroRNA in disease regulation (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer Cells and Metastasis (4 papers) and Mitochondrial Function and Pathology (4 papers). The work is most often cited by research in Drug Discovery (58 citations), Cancer Research (570 citations), Biochemistry (288 citations), Pharmacology (363 citations) and Biomaterials (230 citations). Marek Samec has collaborated with scholars based in Slovakia, Qatar and United States. Frequent co-authors include Peter Kubatka, Alena Líšková, Dietrich Büsselberg, Lenka Koklesová, Olga Golubnitschaja, Samson Mathews Samuel, Kamil Biringer, Frank Anton Giordano, Erik Kúdela and Elizabeth Varghese. Their work appears in journals such as The EPMA Journal, International Journal of Molecular Sciences, Cancers, Biomolecules and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.